The article highlights the personal journeys of two women, Deepti Pradhan and Christine Ngaruiya, both affected by breast cancer, who underscore the importance of NIH-funded research. Despite its significant role in advancing medical treatments and economic activity, the NIH faces funding cuts and policy changes that threaten vital research infrastructure. These changes come at a time when noncommunicable diseases, including cancer, are the leading causes of death in the U.S. There are concerns about the implications these cuts will have on future advancements in medical research and care.
"As a patient and a physician, we have directly benefited from medical advances, from chemotherapy to diagnostics. Yet today, that very research is at risk."
"The NIH, the world's largest public funder of biomedical and public health research, spent over $35 billion in 2023, generating an estimated $92.89 billion in economic activity."
Collection
[
|
...
]